title: New hysteroscopic techniques for submucosal uterine fibroids.
abstract: OBJECTIVE
  To review the preoperative preparation, intraoperative equipment and techniques to facilitate hysteroscopic resection of submucous fibroids.
  
  
  RESULTS
  The use of preoperative ultrasound can guide safe resection of submucous fibroids and should be an integral part of a preoperative workup. The data regarding misoprostol use for cervical dilation prior to hysteroscopy is somewhat conflicting and the decision to preoperatively administer misoprostol should be on a case-by-case basis. Hysteroscopic resection of submucous intrauterine fibroids can now be performed under low-dose spinal anesthesia and with the development of smaller instruments and bipolar technology, in an office-based setting without any anesthesia and, sometimes, analgesia. Although the complete removal of type 1 and 2 submucous fibroids remain a challenge, the development of newer techniques such as office preparation of partially intramural myomas and cold-loop myomectomy can result in better removal of these submucous fibroids with an intramural component.
  
  
  CONCLUSIONS
  Hysteroscopic resection of submucous uterine fibroids should be a simple, well tolerated and effective procedure. Innovations to the existing hysteroscopic techniques and the development of the hysteroscopic morcellator will hopefully result in a greater number of gynecologic surgeons being able to safely perform hysteroscopic resection of submucous uterine fibroids.
authors.affiliation: Department of Obstetrics and Gynecology, Jones Institute for Reproductive Medicine, Eastern Virginia Medical School, Norfolk, Virginia, USA.
authors.forename: Tarita
authors.initials: T
authors.lastname: Pakrashi
mesh_terms: D005260:Female; D006801:Humans; D015907:Hysteroscopy / Q000379:methods; D007889:Leiomyoma / Q000150:complications / Q000473:pathology / Q000601:surgery*; D016595:Misoprostol / Q000008:administration & dosage; D010120:Oxytocics / Q000008:administration & dosage; D018579:Patient Selection; D016896:Treatment Outcome; D014592:Uterine Hemorrhage / Q000209:etiology / Q000473:pathology / Q000601:surgery*; D063186:Uterine Myomectomy / Q000379:methods; D014594:Uterine Neoplasms / Q000150:complications / Q000473:pathology / Q000601:surgery*
chemical_list: D010120:Oxytocics; D016595:Misoprostol